Natco Pharma’s Hyderabad API plant receives EIR from U.S. FDA

Generic drugmaker Natco Pharma has received an establishment inspection report from the U.S. Food and Drug Administration for its active pharmaceutical ingredient manufacturing facility in Hyderabad.